Establishing A Research Function In Biopharma
Source: Life Science Leader
By Matthew Pillar, Editor, Bioprocess Online
For nearly 18 years, Robert Stoffel, Ph.D., was an institution at AbbVie, working his way up from principal scientist to senior director of immunology and antibody-drug conjugate over that span. That long run followed more than seven years at BMS. But late in 2021, Stoffel left the comforts of Big Bio for a new challenge with fast-moving Horizon Therapeutics.
access the Magazine Article!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.
Subscribe to Life Science Leader
X
Subscribe to Life Science Leader
This website uses cookies to ensure you get the best experience on our website. Learn more